Form 4: Mirum Pharmaceuticals Executive Exercises Stock Options and Sells Shares

A Mirum Pharmaceuticals executive, Jolanda Howe, exercised stock options and sold shares on November 14, 2024.

Summary

• Jolanda Howe, SVP, Global Controller at Mirum Pharmaceuticals, executed a transaction involving the company's stock on November 14, 2024.
• She exercised stock options to acquire 2,500 shares at a price of $2.94 per share.
• Following the exercise, she sold 2,500 shares at a price of $47.1008 per share.
• After these transactions, Ms. Howe directly owns 2,426 shares of Mirum Pharmaceuticals stock.

Sentiment

Score: 5

Explanation: This is a neutral transaction, reflecting routine executive compensation activity. It doesn't indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to executive stock option exercises and sales, which is common in publicly traded companies. It provides transparency into insider transactions.

Comparison to Industry Standards

• Executive stock option exercises and sales are a standard practice in the pharmaceutical industry.
• The vesting schedule described is typical for stock options granted to employees and executives.
• Form 4 filings are a common regulatory requirement for publicly traded companies in the US, ensuring transparency of insider transactions.

Stakeholder Impact

• This transaction has a minimal impact on shareholders as it is a routine executive stock transaction.

Key Dates

Keywords

Mirum Pharmaceuticals, stock options, insider trading, Form 4, equity, share sale, executive compensation